Category: Corporate Announcement

Sakar submitted 20 dossiers of oncology product registration across regions

Sakar Interaction with Investor 8th October 2022

FPI Investment in Sakar Healthcare

Sakar enters into agreement with 7-partners

Sakar Healthcare enters into an Agreement with Zydus Life Sciences (Cadila Healthcare) to manufacture Oncology

Stakeholder Communication

Intimation Letter under regulation 30 of SEBI (LODR) Regulations, 2015, 19th January 2018

Sakar s oncology (anti-cancer) unit receives EU GMP approval

Sakar Interaction with Investor 29th Sept. and 1st October 2022

Amendment in Memorandum of Association